More than four years after Amgen’s cholesterol-lowering antibody Repatha was approved in the US, the company still can’t generate much sales momentum behind the product. Its latest gambit is to make ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Propel your future with a Top 50 Poets&Quants ranked, AACSB-accredited business education. The UD School of Business Administration offers nine undergraduate degree programs and 12 minors to help ...

If you need medicine to lower your cholesterol, chances are your doctor will prescribe a statin. But these drugs aren’t always enough. And some people can’t take them because of their side effects.

News about the Donald Trump White House administration, including comment and features from the Guardian Trump threatens to bomb Oman if it ‘gets in the way’ of Iran deal as Kushner meets Netanyahu – ...

An in-depth look at the immigration, environment, economy and foreign policies of the Trump administration, from the Los Angeles Times. The government is appealing the May ruling by U.S. District ...